Alpine Global Management’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-776
Closed -$301K 332
2022
Q4
$301K Buy
+776
New +$219K 0.1% 79
2022
Q2
Sell
-533
Closed -$363 603
2022
Q1
$363 Hold
533
0.08% 123
2021
Q4
$369K Buy
533
+33
+7% +$24.4K 0.05% 422
2021
Q3
$370K Sell
500
-16
-3% -$10.9K 0.08% 153
2021
Q2
$386K Sell
516
-17
-3% -$13K 0.05% 157
2021
Q1
$435K Hold
533
0.04% 178
2020
Q4
$455K Buy
+533
New +$411K 0.09% 111

Other funds holding OM

Alpine Global Management's OM Position: Q1 2023 in Review

Alpine Global Management sold out of Outset Medical (OM) in Q1 2023, closing a stake of 776 shares — an estimated $301K sold.

Alpine Global Management first reported a position in OM in Q4 2020 and held it in 7 quarters. The position peaked at $455K in Q4 2020. 162 funds tracked by Wall St. Rank hold OM as of Q1 2023.

  • Alpine Global Management reported no remaining Outset Medical position as of Q1 2023 after selling out during the quarter.
  • Alpine Global Management sold 776 Outset Medical shares in Q1 2023, an estimated $301K.
  • Alpine Global Management first reported a position in Outset Medical in Q4 2020 and held it in 7 quarters.
  • Alpine Global Management's Outset Medical position peaked at $455K in Q4 2020.
  • 162 funds tracked by Wall St. Rank held Outset Medical as of Q1 2023.

Based on Alpine Global Management's 13F filing for Q1 2023, filed 15 May 2023.